1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Liver Steatosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonopoulou, S; Detopoulou, P; Fragopoulou, E; Nomikos, T | 1 |
| Feldstein, AE; Latchoumycandane, C; McIntyre, TM; McMullen, MR; Nagy, LE; Papouchado, BG; Pratt, BT; Yang, L; Zhang, R | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Liver Steatosis
| Article | Year |
|---|---|
Association of PAF and its Metabolic Enzymes with GGT and the Fatty Liver Index in Healthy Volunteers.
Topics: Fatty Liver; Female; gamma-Glutamyltransferase; Healthy Volunteers; Humans; Male; Platelet Activating Factor | 2021 |
Chronic alcohol exposure increases circulating bioactive oxidized phospholipids.
Topics: Administration, Oral; Alcoholism; Animals; Diet; Ethanol; Fatty Liver; Feeding Behavior; Humans; Liver; Oxidation-Reduction; Oxidative Stress; Phospholipids; Platelet Activating Factor; Rats; Rats, Wistar; Taurine; Time Factors; Tumor Necrosis Factor-alpha | 2010 |